Private company

Allakos Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address4757 Executive Drive, Suite 210, San Diego, Ca 921212
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income34567-$122.2M in 2024+167% since 2018
-$400.0M-$300.0M-$200.0M-$100.0M02018: -$45.7M-$45.7M20182019: -$91.4M-$91.4M2019+100%2020: -$157.1M-$157.1M2020+72%2021: -$271.5M-$271.5M2021+73%2022: -$322.4M-$322.4M2022+19%2023: -$196.1M-$196.1M2023−39%2024: -$122.2M-$122.2M2024−38%
Net income3458-$115.8K in 2024−100% since 2018
-$300.0M-$200.0M-$100.0M02018: -$43.5M-$43.5M20182019: -$85.4M-$85.4M2019+96%2020: -$153.5M-$153.5M2020+80%2021: -$269.9M-$269.9M2021+76%2022: -$320.0K-$320.0K2022−100%2023: -$185.7K-$185.7K2023−42%2024: -$115.8K-$115.8K2024−38%
Fiscal year20182019202020212022202320242025
Research and development$33.3M3$61.9M4$105.5M5$196.3M5$265.1M6$150.9M7$79.9M7
Operating income-$45.7M3-$91.4M4-$157.1M5-$271.5M5-$322.4M6-$196.1M7-$122.2M7
Income tax$012$012
Net income-$43.5M3-$85.4M4-$153.5M5-$269.9M5-$320.0K8-$185.7K8-$115.8K8
Earnings per share-$3.105-$5.015-$5.066-$2.147-$1.307
Earnings per share (diluted)-$3.105-$5.015-$5.066-$2.147-$1.307

Compare Allakos Inc. with another company

Recent filings

  1. May 19, 20254 OWNERSHIP DOCUMENT
  2. May 15, 20258-K
  3. May 15, 20254 OWNERSHIP DOCUMENT
  4. May 15, 20254 OWNERSHIP DOCUMENT
  5. May 15, 20254 OWNERSHIP DOCUMENT
  6. May 15, 20254 OWNERSHIP DOCUMENT
  7. May 15, 20254 OWNERSHIP DOCUMENT
  8. May 15, 20254 OWNERSHIP DOCUMENT
  9. May 15, 20254 OWNERSHIP DOCUMENT
  10. May 15, 20254 OWNERSHIP DOCUMENT
  11. May 15, 20254
  12. May 7, 202510-Q
  13. Apr 17, 202510-K/A
  14. Apr 2, 20258-K
  15. Mar 13, 20258-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1